Posts by: Charles Moore

Charles Moore

Charles Moore is a syndicated columnist for several major Canadian print newspapers and the Science and Research Section editor for CF News Today.

August 15, 2017

Kate Farms Launches Core Essentials Peptide Tube Feeding Formula for CF, Other Conditions

News

Kate Farms, which specializes in plant-based, ready-to-use oral and tube feeding formulas, has rolled out its Core Essentials Peptide 1.5 product. The high-caloric, peptide-based formula contains no dairy, soy, gluten, ... Read more

November 9, 2016November 9, 2016

Fluorescent Light Detector Seen to Easily Diagnose CF Through Sweat Chloride Levels

News

Scientists at Pennsylvania State University have developed a relatively inexpensive, easy-to-use system for diagnosing cystic fibrosis (CF), a technique that uses florescent light to measure levels of chloride in perspiration, which ... Read more

November 3, 2016November 3, 2016

Boomer Esiason Foundation Seeks 2016-17 ‘Sacks for CF Scholarship’ Applicants

News

The Boomer Esiason Foundation (BEF) announced the Sacks for CF Scholarship for 2016-17, which are funding grants for college students who have cystic fibrosis (CF). Awards for undergraduates and ... Read more

October 24, 2016October 24, 2016

#NACFC2016 – Therapies, Lung Transplants and Registries Among Topics at CF Conference Opening Thursday

News

The 30th Annual North American Cystic Fibrosis Conference (NACFC), a three-day collaborative forum to help advance cystic fibrosis (CF) understanding, treatment and research, opens on Thursday, Oct. 27, at the ... Read more

October 6, 2016October 6, 2016

Researchers Are Developing Mobile App to Help Manage, Monitor CF Patients

News

A team of 12 research partners in seven European countries are engaged in a project to develop a mobile app designed to promote autonomy and help people with cystic fibrosis (CF), ... Read more

September 30, 2016September 30, 2016

FDA Approves Orkambi for Children, Ages 6-11, with Cystic Fibrosis

News

Vertex Pharmaceuticals reported that the U.S. Food and Drug Administration (FDA) has granted approval for its cystic fibrosis (CF) drug Orkambi to be used to treat children, ages 6 to 11, who ... Read more

August 23, 2016August 23, 2016

Data on Inhaled CF Therapy in Clinical Testing To Be Presented at NACFC 2016

News

ProQR Therapeutics announced that it plans to announce proof-of-concept results from tests of its lead candidate to treat cystic fibrosis (CF), QR-010, at a scientific conference this year, and is continuing ... Read more

June 3, 2016June 3, 2016

Irish CF Groups Disappointed in Government’s Funding Rejection of Orkambi as Not Cost Effective

News

Ireland’s National Centre for Pharmacoeconomics (NCPE) stirred the pot this week with its decision that the cost of the new cystic fibrosis (CF) drug Orkambi is not justified by ... Read more

April 15, 2016April 15, 2016

Wearable and Battery-Free ‘Sweat Sensor’ to Monitor CF Developed at Dutch University

News

Researchers at Eindhoven University of Technology (Technische Universiteit Eindhoven-TU/e), in the Netherlands, have developed a device that takes in water at one end and ‘pumps’ it to the other, maintaining ... Read more

March 24, 2016March 24, 2016

Microsoft’s Xbox Kinect Devices Used to Develop New Way of Assessing CF Lung Health

News

A new technique using relatively inexpensive Microsoft Xbox Kinect gaming devices could soon be used to assess the respiratory health of patients with conditions such as cystic fibrosis (CF). ... Read more